CLINICAL_TRIALS
trial_result
· 2021-01-05
Clinical Trial Update: Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department [Phase 3]
Summary
Clinical trial update for intranasal lidocaine to treat pediatric migraine in the emergency department in Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York City Health and Hospitals Corporation | Conditions: Migraine | Phase 3 | Status: UNKNOWN